|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02279 YONGHE MEDICAL
Nominal 
1.880 -0.090 (-4.569%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 4.300% | -10.854% | -20.331% | -2.801% | 5.014% |
| ROAE (%) | 9.812% | -27.321% | -43.230% | -5.229% | 11.423% |
| Return on Capital Employed (%) | 6.396% | -19.174% | -31.736% | -3.531% | 4.882% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 66.041% | 60.084% | 56.108% | 61.763% | 72.858% |
| EBITDA Margin (%) | 20.035% | 5.016% | -11.079% | 4.463% | 21.077% |
| Pre-tax Profit Margin (%) | 5.831% | -14.147% | -32.928% | -7.748% | 9.696% |
| Net Profit Margin (%) | 4.076% | -12.543% | -30.744% | -6.077% | 5.542% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.554 X | 1.154 X | 1.120 X | 2.386 X | 2.370 X |
| Quick Ratio (X) | 1.530 X | 1.080 X | 1.014 X | 2.209 X | 2.298 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 53.734% | 58.648% | 61.455% | 45.901% | 46.915% |
| Total Debt / Total Assets (%) | 28.479% | 38.648% | 44.816% | 35.340% | 31.930% |
| Net Debt / Total Assets (%) | -12.593% | 10.387% | 20.140% | 16.056% | -17.024% |
| Total Debt / Shareholders' Funds (%) | 61.502% | 93.392% | 116.232% | 65.325% | 60.149% |
| Long Term Debt / Shareholders' Funds (%) | 46.249% | 65.310% | 81.978% | 53.305% | 44.885% |
| Net Debt / Shareholders' Funds (%) | -27.196% | 25.099% | 52.234% | 29.679% | -32.070% |
| Net Cash / (Debt) ($) | 214.320M | (179.291M) | (492.338M) | (470.509M) | 544.661M |
| Net Cash / (Debt) per share ($) | 0.408 | (0.341) | (0.934) | (0.893) | 1.048 |
| Total Debt / Capital Employed (%) | 42.053% | 56.514% | 63.634% | 42.585% | 41.498% |
| Interest Coverage Ratio (X) | 5.579 X | N/A | N/A | N/A | 5.048 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 16.000 Day | 29.528 Day | 38.390 Day | 47.711 Day | 24.846 Day |
| Receivables Turnover (Day) | 1.457 Day | 1.507 Day | 1.779 Day | 2.636 Day | 1.993 Day |
| Payables Turnover (Day) | 9.383 Day | 12.571 Day | 12.670 Day | 10.338 Day | 6.794 Day |
| Remarks: | Real time quote last updated: 02/04/2026 12:36 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 73,711 |
| %Change | -- |
| EPS / (LPS) | RMB 0.150 |
| NBV Per Share (¥) | RMB 1.500 |